On this Ropes & Gray podcast, health care partner Michael Lampert and counsel Sam Perrone, and litigation & enforcement partner Andrew O’Connor, rejoin to discuss patient assistance programs, recent ...

Patients with retinal diseases who were treated with anti-VEGF therapies through manufacturer patient assistance programs ...

In the rapidly evolving landscape of healthcare, Pharma Patient Assistance Programs (PAP) have been a lifeline for many patients seeking access to essential medications. These programs aim to help ...

On June 17, 2024, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) posted a favorable Advisory Opinion 24-03 (“AO 24-03”) involving a pharmaceutical manufacturer’s ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

One of the most powerful components of the Affordable Care Act (ACA) was the mandate that nonprofit hospitals provide an income-based financial assistance program. But 10 years after the passage of ...

When Gury Doshi, MD, learned that a patient’s insurance didn’t cover her breast cancer medication, Doshi had a potential workaround. The patient could try to bypass the insurer and access the drug at ...

You may qualify for free Restasis through the drug’s manufacturer, myAbbVie Assist. That said, you won’t use your Medicare coverage. Restasis (cyclosporine), a brand-name eye drop for chronic dry eyes ...

Ten case studies were conducted between December 2001 and March 2002 to identify critical issues to be explored more widely in a multistate telephone survey. The case-study sites were selected to ...

Efficacy of Subsequent Treatments After Disease Progression on CDK4/6 Inhibitors in Patients With Hormone Receptor–Positive Advanced Breast Cancer Eligible patients were diagnosed with cancer and ...

As a rheumatologist, I see every day how rising health care costs strain my patients. Premium hikes and higher pharmacy expenses affect many, but those living with chronic autoimmune diseases bear the ...